July 29, 2016 11:41 AM ET

Pharmaceuticals

Company Overview of OctoPlus N.V.

Key Executives for OctoPlus N.V.

NameBoard RelationshipsTitleAge
Jan Hendrik Egberts M.D., Ph.D.77 RelationshipsChief Executive Officer and Member of Executive Board56
Susan M. Swarte 4 RelationshipsChief Financial Officer and Member of Executive Board46

OctoPlus N.V. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.) 32 RelationshipsDr. Reddy's Laboratories Ltd.56
Daan Crommelin Ph.D. 10 RelationshipsAGLAIA BioMedical Ventures B.V.--
Douwe D. Breimer Ph.D. 20 RelationshipsLife Sciences Partners BV--
W. E. Hennink 7 RelationshipsOctoPlus N.V.--
Peter van Brummelen Ph.D., M.D. 15 RelationshipsEnceladus Pharmaceuticals BV73
View All Board Members

OctoPlus N.V. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Supervisory Board B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)Gunupati Venkateswara Prasad32 Relationships3 Executives
Advisory Board Ph.D.Daan Crommelin10 Relationships5 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$477.2K
477.2K
436.1K
Bonus$190.9K
190.9K
535.1K
Total Short Term Compensation$668.0K
668.0K
642.2K
Total Value of Options
20.5M
Compensation as of Fiscal Year
OctoPlus N.V. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Benchmark Holdings plc Announces Directorate Changes
July 29, 2016 6:00 AM ET
Valeant Pharmaceuticals International, Inc. Appoints Sarah B. Kavanagh as Director of the Board
July 28, 2016 9:00 PM ET
Agile Therapeutics, Inc. Announces Board Changes
July 28, 2016 8:30 PM ET
Novartis India Ltd. Announces Resignation of Girish Tekchandani as Company Secretary & Compliance Officer, Effective August 12, 2016
July 28, 2016 9:29 AM ET
RPG Life Sciences Limited Appoints Mr. Yugal Sikri as an Additional Director
July 28, 2016 8:47 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact OctoPlus N.V., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.